Expanding on previously reported results in the overall population, new prespecified subgroup analyses showed greater Week 24 combined fistula remission with TREMFYA versus placebo among: 1 Perianal ...
Remission and Endoscopic Response with RINVOQ for Advanced and Difficult-to-Treat Crohn's Disease ...
ABBV's Skyrizi and Rinvoq are expected to drive Q3 growth, offset Humira's ongoing decline and face rising competition in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results